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1. Introduction 
Anemia is reported to be the most common blood disorder. A variety of anemic conditions 
affecting various groups of people exist and each of the types of anemia has different 
underlying causes. Iron (Fe) deficiency, a potent instigator of anemia, is the most common 
mineral deficiency and its effects have been linked to slow physical development and 
impaired cognitive function along with behavioral and learning disturbances (De Giudice et 
al, 2009). Exacerbating the iron deficiency epidemic is obesity, a disease defined by an excess 
accumulation of body fat leading to adverse health effects. It has been demonstrated that 
there is an association between poor iron status and obesity. The relationship between the 
two conditions has been shown in children, adolescents and adults including post-
menopausal women.  
Obesity is now considered an independent factor contributing to iron deficiency (McClung 
et al, 2009). Gaining incredible importance as a global health issue, obesity rates are 
increasing worldwide. The World Health Organization estimated that in 2005, 1.6 billion 
adults were overweight (body mass index (BMI) =25), and over 400 million adults were 
obese (BMI =30). Notably, there is an increase in the incidence of childhood and adolescent 
obesity in industrialized countries where the number of affected population has more than 
doubled over the past few decades. A similar trend has been observed in developing 
countries such as Egypt, Brazil and Mexico. What used to be considered a “rich” country 
issue has now become a worldwide epidemic and the situation is continuously worsening 
(Hintze et al, 2010).  
2. Hepcidin: Function and regulation 
A significant proportion of the world's population is iron-deficient, obese, or both. This 
makes an understanding of the mechanisms underlying obesity-induced iron deficiency and 
anemia crucial. Recently, the discovery of the peptide hormone hepcidin, a regulator of 
organismal iron metabolism has shed light on the relationship between anemia and obesity. 
Hepcidin is a 25 amino acid long peptide secreted by the liver and adipose tissue that was 
initially studied for its modulation of iron-homeostasis during infection. Increases in 
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hepcidin levels cause the depletion of serum iron levels and prevent the efflux of iron 
through the cellular iron exporter ferroportin from hepatocytes, enterocytes and 
macrophages (Figure 1). Therefore, hepcidin is the iron/inflammation/oxygen sensor that 
can act as a signal for numerous physiological responses including i) the decreased dietary 
iron uptake during an overload situation, ii) the anemia seen during infection to prevent 
free iron from promoting pathogen proliferation and iii) an increase of iron uptake during 
hypoxia (Atkinson et al, 2011; Choi et al, 2007; Vecchi et al, 2009).  
 
 
Fig. 1. Al toxicity leads to an increased Fe concentration in the serum of the body. High 
blood Fe levels cause the liver and adipose tissue to secrete hepcidin, a Fe homeostasis 
regulator, which signals the decrease in Fe absorption by enterocytes as well as a decrease in 
Fe release from cellular stores such as red blood cells. 
Interestingly, chronic inflammation is one of the hallmarks of obesity (Ausk et al, 2008, 
Yanoff et al, 2007). Adipose tissue in obese mice has been shown to be considerably more 
hypoxic than adipose tissue from lean mice. As a result of the difference in O2 tension there 
is an important shift in gene expression, not only for expected genes induced by hypoxia but 
also the increased levels of inflammatory cytokines including interleukin-6 (IL-6) (Lee et al, 
2005). The latter appears to be the mediator of the induction of hepatic hepcidin secretion 
during inflammation. IL-6 and other hepcidin-inducing factors such as the adipokine leptin 
may explain the increased hepcidin levels in obese individuals compared to healthy patients 
(Barisani et al, 2008; Choi et al, 2007; Hintze et al, 2010). 
3. The link between Fe-deficiency, anemia, inflammation and obesity 
When studied separately, the development of anemia, inflammation and obesity have all been 
associated with aluminum (Al) toxicity. It is well established that Al disrupts iron homeostasis 
leading to the dysfunction of essential biochemical processes dependent on this redox-active 
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ion. Al negatively influences the absorption of iron via the intestine, hinders its transport in the 
serum, and displaces iron by binding to transferrin (Figure 2) (Turgut et al, 2007).  
 
 
 
 
 
Fig. 2. Al has various toxic effects on cellular processes, notably on Fe homeostasis. 
Al plays an important role in the immune response by being a trigger of the inflammatory 
cascade. For this reason, Al salts are administered with vaccines and act as adjuvants. Al 
stimulates an inflammatory response which promotes the effectiveness of the immune 
system to respond to the vaccine and acquire immunity. The effect of Al toxicity on fatty 
acid metabolism is just starting to emerge. The modulation of energy metabolism at the 
mitochondrial level caused by this metal leads to an accumulation of triglycerides and an 
increase in fat deposits. In addition, there is a marked increase in very low density 
lipoprotein (VLDL) secretion caused by Al toxicity. This phenomenon is directly related to 
the accumulation of fatty tissue observed during obesity. The information presented in this 
chapter delineates the molecular mechanism of Al toxicity and thus affords insights into the 
implication of this metal in dysfunctional Fe homeostasis, inflammation, obesity and 
anemia.  
4. Aluminum and the environment 
Aluminum is an environmentally abundant element that has a wide variety of uses and 
industrial applications. Industrialization and anthropogenic activities have led to a further 
increase in bioavailable Al. Exposure to this non-redox active metal occurs in daily life 
where the major sources of exposure for the average individual are diet and drinking water. 
Additional aluminum exposure can be brought upon by certain medications such as 
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antacids, while individuals can also be subjected to high Al levels due to occupational 
exposure from breathing in contaminated air. Although drinking water was first thought to 
be the main delivery method of Al to the body, it was shown that 95% of the exposure to the 
element occurs through diet whereas the soluble water form of Al only accounts for 1-2%. 
The average human Al intake ranges between a total of 4 to 9 mg/day. Although small, 
these values are easily influenced by factors such as the type of food consumed in one’s diet, 
the country/place of residence, one’s age and sex. Alternate sources contribute to the 
amount of Al an individual is subjected to (Table 1), with antacids representing a significant 
dose, as they are generally composed of aluminum hydroxide salts (Lopez et al, 2002; et al, 
2006; Yokel et al, 2008b).  
 
Source Al exposure contribution 
Antacids  5000000 μg/day 
Environmental air inhalation  4-20 μg/day 
Industrial air inhalation 25000 μg/day 
Antiperspirants 70000 μg/day 
Cigarettes 500-2000 μg/cigarette 
Vaccines 1-8 μg/day 
Allergy immunotherapy  7-40 μg/day 
Table 1. Various sources of Al and their average Al exposure contribution (Yokel et al, 
2008b).  
The use of aluminum salts is not restricted to stomach acidity neutralizing agents, but are 
rather quite frequently used in the food industry. Sodium aluminum phosphates (SALPs) 
are generally recognized as safe (GRAS) FDA-approved food additives that contribute the 
most important source of Al to the diet. Basic SALP (Na8Al2(OH2)((PO)4)4) is one of the 
many emulsifying salts added to processed cheese, cheese food and cheese spread. This salt 
is added to cheese since it reacts with proteins resulting in modifications that produce a 
smooth, uniform film around each fat droplet, preventing separation and bleeding of fat 
from cheese. Ultimately this allows for a soft texture, easy melting characteristics and 
desirable slicing properties. The FDA approves up to 3% concentrations of basic SALP. 
Unprocessed cheese has been shown to have an Al concentration of < 10 mg Al/kg. In 
contrast the aluminum levels in processed cheese can range from 320-1440 mg Al/kg. 
Cheese is not the only processed food containing higher levels of aluminum. Both fruit 
juices and soft drinks contain aluminum levels ranging from 49.3 to 1144.6 μg/l in fruit 
juices and from 44.6 to 1053.3 μg/l in soft drinks respectively (Lopez et al, 2002). The benefits 
of processed foods include a longer shelf life, change in taste and texture, minimal meal 
preparation and lower cost. The increased consumption of processed food has been shown 
to be related to the rise in obesity rates in industrialized nations for many reasons including 
the high simple sugar levels. Perhaps the high levels of Al found in processed food are 
amplifying the risk of obesity that is associated with food processing (Figure 3) (Yokel et al, 
2008a; 2008b; 2006).  
The food processing industry is responsible for an increase in bioavailable Al, however it 
is not working alone. Industrialization has led to a higher frequency of acid rain which in 
www.intechopen.com
The Molecular Connection Between  
Aluminum Toxicity, Anemia, Inflammation and Obesity: Therapeutic Cues 407 
turn lowers the pH in soil. Consequently, Al is leaching into groundwater thus causing 
the bioaccumulation of this toxic metal in various non-processed food such as vegetation 
and livestock. Once consumed, these sources increase the accumulation of aluminum in 
the body. Various fresh food sources contain relatively high levels of Al, as shown in  
Table 2.  
 
Food Group 
Mean Al 
concentration 
(mg/kg of fresh 
weight) 
Food Group 
Mean Al 
concentration 
(mg/kg of fresh 
weight) 
Bread 6.6 Potatoes 0.9 
Poultry 0.3 Canned vegetables 0.97 
Fish 6.1 Fresh fruit 0.29 
Oils & fats 1.1 Fruit products 0.82 
Eggs 0.14 Milk 0.07 
Green vegetables 3.1 Nuts 4.0 
 
Table 2. Occurrence of Al in food according to the Food Standards Agency, United 
Kingdom. 
Aluminum toxicity has been extensively studied for its implication in neurodegenerative 
diseases such as Alzheimer’s disease (AD) and multiple sclerosis (MS). The brain is an 
important Al accumulating organ, yet Al can also concentrate more severely in other tissues 
of the human body (Figure 4) (Gomez et al, 2008; Rondeau et al, 2008). Nonetheless, 
aluminum salts such as aluminum hydroxides and aluminum phosphates are routinely used 
in medical practices as the only licensed adjuvants in vaccines. Aluminum adjuvants, 
referred to as “alum”, are proven effective in stimulating an immune response towards the 
vaccine being administered. However, the mode of action remains unclear. It is generally 
accepted that the alum particles adhere to the surface of the antigen (Ag), forming an Ag 
deposit at the injection site. This process maximizes the interaction time between the Ag and 
the immune system’s antigen presenting cells (APCs) which initiate a response cascade 
(Figure 4). Alum have also been shown to act on the immune system’s compliment system 
of the immune machinery, along with causing the formation of granulomas containing 
antibody (Ab)-producing cells and other immune response mediators. Recent studies have 
illustrated the ability of alum to stimulate the release of pro-inflammatory cytokines such 
as IL-1ǃ and IL-18 that have pleiotropic functions, including adjuvant capacity. Although 
several mechanisms are proposed (Figure 5), the exact way by which aluminum promotes 
inflammation has yet to be solved (Aimanianda et al, 2009; HogenEsch, 2002; Li et al, 
2008). Nonetheless, Al is an active instigator of inflammation (Campbell et al, 2002). 
Regardless of the source of Al the reality remains that the element is bioavailable and at 
significant concentrations. For this reason, the toxic effects of Al are of interest to the 
human population and the study of these effects could help explain Al-associated 
dysfunctions such as neurodegenerative diseases, obesity and chronic inflammation. More 
importantly, the link between these disease states, aluminum toxicity and anemia is 
beginning to be understood.  
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Fig. 3. These maps illustrate the link between processed food (commonly served in the fast 
food industry or found in prepared meals) and the obesity epidemic in the United-States. A) 
Adult obesity rate in 2007. Grey (12.5% - 25%). Light blue (25.1% - 30%). Blue (30.1% - 35%). 
Dark blue (35.1% - 43.5%); B) Low-income preschool obesity rate in 2008. Light pink (2.1% - 
10%). Pink (10.1% - 14%). Red (14.1% - 18%). Dark red (18.1% - 39.7%); C) Fast food 
expenditure per capita in 2007. Light pink ($402.10 - $500.00). Pink ($500.01 - $700.00). Red 
($700.01 - $1,043.86). D) Prepared food (lbs) per capita in 2006. Grey (229 - 280lbs). Light 
green (281 - 300lbs). Green (301 - 320lbs). Dark green (321-374lbs). (Centers for Disease 
Control and Prevention). 
 
A)                                                                             B) 
C)                                                                              D) 
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Fig. 4. The hierarchy of Al accumulation in the various tissues of the human body. Although 
the brain is an important location for Al accumulation, there are many other organs that 
accumulate much greater concentrations of Al (Ward et al, 2001).  
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Fig. 5. Proposed mechanism of action for Al being used as an adjuvant A) As a vaccine is 
injected into the skin, the alum adjuvant bound to the Ag form a deposit at the injection site. 
This promotes APC recruitment and maximizes the interaction between the Ag and the 
immune system’s cells. B) The innate immune system cells intake the Alum salts. C) The 
engulfed adjuvants interact with the phagolysosome of the APCs. D) Intereaction with the 
Alum salts leads to rupture of the phagolysosomes and the release of activators of NLRP3 
inflammasome (not shown in image). E) Al within the cell promotes the formation of ROS 
which also activates the NLRP3 inflammasome. F) The Alum salts also lead to potassium 
(K+) efflux, thus further activating the NLRP3 inflammasome. G) The NLRP3 
inflammasome, an intracellular innate immune response system, senses the K+ efflux, the 
ROS formation and the lysosomal damage and activates caspase-1. H) Caspase-1 processes 
pro-IL-1ǃ and pro-IL-18 into IL-1ǃ and IL-18, respectively, resulting in the release of these 
mature cytokines (Modified from Aimanianda et al, 2009; HogenEsch, 2002; Li, 2008). 
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5. Aluminum and dyslipidemia: A metabolic perspective  
Metal toxicity has been linked to cancers, neurological disorders, nephrological 
complications and pulmonary diseases. Environmental pollution is a growing concern in 
today’s society causing the increased bioavailability of metals that pose a serious threat to 
living organisms. Toxic elements like mercury (Hg) and lead (Pb) have been extensively 
studied. While Hg has been shown to react with critical thiol moieties and impede normal 
immunological responses and mental cognition, Pb dislocates the essential zinc (Zn) found 
in enzymes responsible for heme production. Ultimately these toxic metals lead to various 
diseases (Mailloux et al, 2007b). The molecular aspects of Al toxicity have begun to emerge. 
It has been reported that a variety of ion channels are inactivated by micromolar quantities 
of Al, subsequently disrupting biological membranes. In addition, Al has an ionic radius 
that resembles that of magnesium (Mg), which leads to its interaction with naturally-
occurring Mg-dependent enzymes. Al has also been shown to perturb cytoskeletal structure 
of astrocytoma cells causing a disruption of their shape and hence their biological function. 
Exposure to Al, however, is primarily characterized by the disruption of Fe homeostasis 
which in turn interferes with essential biochemical processes that are dependent on this 
metal (Lemire et al, 2009; Mailloux et al, 2011).  
Fe is an important cofactor of many enzymes and a structural component of proteins. It is 
redox-active and therefore can act as an electron acceptor and donor, a critical attribute for 
its involvement in metabolic processes. Notably, Fe is required for protein components such 
as iron-sulfur clusters (Fe-S clusters) and hemes. When Al interacts with these constituents, 
it mimics the Fe atoms forcing the liberation of the transition metal and its subsequent 
intracellular accumulation. Free Fe poses a threat to cells as it leads to the formation of 
reactive oxygen species (ROS) through Fenton chemistry (figure 6). The Al-triggered 
oxidative environment enhances the toxic effect of the trivalent metal. Together, Al and its 
concomitant ROS greatly affect cellular metabolism. Metabolism is the foundation of any 
biological system and metabolic processes allow organisms to react and adapt to 
intracellular and extracellular fluctuations. It enables the maintenance of an environment 
suitable for the production and storage of energy and for cellular growth (Kim et al, 2007; 
Mailloux et al, 2011; Vergara et al, 2008).  
The importance of Fe as a cofactor in metabolic processes is made evident in energy 
metabolism. The redox active metal is essential for the ATP-producing machinery in the 
mitochondria of eukaryotes. The central metabolic pathway known as the tricarboxylic acid 
cycle (TCA cycle), along with the electron transport chain (ETC) which is responsible for 
oxidative phosphorylation, are composed of enzymes that depend on Fe for proper 
functioning. For example, the Fe-containing enzyme aconitase (ACN) is considered the 
“gatekeeper” to the TCA cycle. ACN are Fe-S cluster proteins that catalyze the reversible 
isomerization of citrate to isocitrate. The enzymatically active form of the ACN Fe-S clusters 
are predominantly [4Fe-4S]. In mammalian systems, ACN with [3Fe-4S] clusters play an 
alternate role, acting as an oxygen sensor therefore aiding in energy homeostasis. This form 
of the enzyme serves as a regulatory protein that controls the stability and translation of 
messenger RNAs (mRNAs) encoding proteins involved in iron and energy homeostasis. The 
regulatory ACN is referred to as iron-responsive protein, which binds to iron-responsible 
elements localized in the RNA-stem loop (figure 7). This action leads to the modulation of 
gene expression (Middaugh et al, 2005).  
It has been demonstrated that cells exposed to Al have severely impeded mitochondrial 
functions. Most importantly, these cells appear to have limited ATP production due to 
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diminished TCA cycle and oxidative phosphorylation activity. As the trivalent metal Al 
displaces Fe in key enzymes of the TCA cycle such as ACN, fumarase (FUM) along with the 
Fe found in enzymes of the ETC (notably succinate dehydrogenase (SDH) and cytochrome C 
oxidase (Cyt c ox)), an evident shift in metabolism occurs as these enzymes become inactive. 
Impairment of ACN by Al triggers a decrease in NADH production by the TCA cycle. 
NADH is a reducing equivalent essential for oxidative phosphorylation, thus as the levels of 
NADH diminish and Al displaces Fe from ETC enzymes, mitochondrial production of ATP 
is hindered (figure 8). This perturbation in oxidative phosphorylation is advantageous 
during Al exposure since the ETC is a known endogenous ROS generator. Inefficient 
electron transport through the chain leads to the univalent reduction of oxygen, a process 
that creates free radical species that exacerbates the toxic effect of Al. It is in a cell’s favor to 
maintain redox homeostasis by limiting its own production of oxidative species during Al-
stressed conditions. In order to meet its energy demands, Al-stressed cells evoke the 
anaerobic respiratory machinery to produce ATP, notably substrate level phosphorylation 
(SLP) (Mailloux et al, 2011; 2007a; 2007b; Middaugh et al, 2005; Lemire et al, 2011a).  
 
 
Fig. 6. Al displaces the Fe in biological molecules such as heme and [Fe-S] clusters. The 
presence of free Fe leads to the formation of ROS.  
Al can severely impede mitochondrial function, however the consequences of its effects are 
not limited to a decrease in energy production. The disruption of oxidative phosphorylation 
by the trivalent metal evokes not only a limited supply of ATP but also an increased lipid 
production. This phenomenon is common in obese individuals who tend to experience 
diminished levels of ATP and an accumulation of fatty tissue. In human liver cells, it has 
been demonstrated that dyslipidemia is due to the ability of Al to perturb iron metabolism 
and promote oxidative stress. By displacing Fe in metabolically active enzymes, Al favors a 
hypoxic environment and stimulates lipogenesis. Lipogenesis is the series of chemical 
reactions leading to the carboxylation and subsequent polymerization of acetyl CoA 
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through the use of the anabolic nucleotide NADPH. Under Al toxicity, pivotal enzymes in 
the lipid production pathway of hepatocytes show an increase in activity. First, acetyl-CoA 
carboxylase (ACC) is up-regulated under ROS and Al-stress conditions. This enzyme is 
responsible for the production of malonyl-CoA, an inhibitor of the transport of lipids into 
the mitochondria and an activator of lipogenesis. Second, glycerol-3-phosphate 
dehydrogenase (G3PDH) diverts trioses from glycolysis into the lipid generating machinery 
by producing glycerol, the backbone of triglycerides. Finally, the much-needed supply of 
NADPH for lipogenesis during Al toxicity is ensured by an ensemble of enzymes including 
glucose-6-phosphate dehydrogenase (G6PDH), 6-phosphogluconate dehydrogenase 
(6PGDH), malic enzyme (ME), NADP+-dependent glutamate dehydrogenase (GDH), NAD 
kinase (NADK) and NADP+-dependent isocitrate dehydrogenase (IDH) (Figure 9). Since Al 
disrupts Fe homeostasis, rendering the TCA cycle and oxidative phosphorylation inactive, 
carbon sources coming from upstream metabolism are funneled towards the production of 
fatty acids. Al toxicity instigates the metabolic shift from NADH production to the synthesis 
of the anabolic reducing agent and antioxidant, NADPH (Figure 10) (Mailloux et al, 2011; 
2007b; Lemire et al, 2008).  
 
 
Fig. 7. ACN is recognized as the “gatekeeper” to the TCA cycle. When the [4Fe-4S] cluster is 
intact, the protein is enzymatically active. However under conditions that favor the [3Fe-4S] 
form of the enzyme, such as Fe starvation, Al toxicity and oxidative stress, the protein is no 
longer metabolically active. ACN [3Fe-4S] acts as the Fe response protein which regulates Fe 
homeostasis at the gene expression level by binding to the Fe responsive element in mRNA 
coding for various genes involved in Fe metabolism.   
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Fig. 8. Al toxicity leads to a disruption of the central metabolic pathways known as the TCA 
cycle. ACN, IDH (NAD-dependent), KGDH and FUM are all hindered under Al stress. This 
limits the production of NADH and therefore oxidative phosphorylation lacks the substrate 
for ATP production. Furthermore, the activity of the ETC enzymes SDH and Cyt C oxidase 
is perturbed under Al toxicity.  
The Al-triggered increase in lipogenesis in liver cells has been recently demonstrated. When 
cultured hepatocytes are stressed with Al, there is a marked increase in lipoproteins and 
cholesterol levels in comparison to non-stressed cultures. ApoB-100 is a glycoprotein that 
plays a critical role in the formation of very low density lipoproteins (VLDL) and low 
density lipoproteins (LDL). As apoB-100 accumulates, insoluble intracellular aggregates 
form leading to their co-translational or post-translational degradation. However, nascent 
apoB-100 is stabilized by the presence of lipids, a process mediated by the microsomal 
triglyceride transfer protein (MTP), ultimately leading to the formation of VLDL and LDL. 
Al leads to the increased lipid production needed to stabilize apoB-100, allowing the 
maturation of VLDL molecules which are subsequently excreted out of the cell. Once out of 
the cells VLDL molecules can be transported to different organs via a receptor-mediated 
process. The concentration of the apoB-100 glycoprotein in the spent media of cultured liver 
cells is directly proportional to the concentration of Al utilized, thus showing direct 
evidence of the link between Al toxicity, lipogenesis and fatty acid accumulation. What is of 
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further interest is the fact that the carbon source used to grow the cultured cells has an effect 
on the concentration of lipids accumulated and the monosaccharide D-fructose, a common 
product in processed food and a compound chemically linked to cancer development and 
obesity, lead to enhanced VLDL secretion in the Al-stressed hepatocytes (figure 9) (Mailloux 
et al, 2007b). 
 
 
Fig. 9. Al toxicity leads to an increase in lipogenesis which can be observed by the increased 
levels of VLDL excreted by Al-stressed hepatocytes. As Al disables the TCA cycle and 
oxidative phosphorylation, there is an accumulation of acetyl-CoA, an important cofactor 
for lipogensis. Al also induces an increase in NADPH production through IDH and G6PDH 
along with an increase in glycerol synthesis, two essential substrates for triglyceride 
synthesis. The elevated levels of lipids in the cell stabilized the glycoprotein ApoB-100, 
leading to the formation and secretion of VLDL (Mailloux et al, 2007b).  
The accumulation of lipids during Al exposure is partially due to the increased lipogenesis 
brought upon by a hindered mitochondrial TCA cycle and ETC. However, the Al stressed 
cells are also unable to degrade lipids, a phenomenon which also contributes to the 
accumulation of fatty acids. L-Carnitine is a non-essential amino acid involved in the 
transport of fatty acid-derived acyl groups into the mitochondria, a key step in the lipid 
degradation process known as ǃ-oxidation. During Al-stressed conditions, L-carnitine levels 
have been shown to decrease in both liver and brain cells. The synthesis of L-carnitine is a 
multistep enzymatic process that requires the participation of lysine, methionine and ǂ-
ketoglutarate (KG). The decrease in L-carnitine levels appear to be triggered by the 
diminished activity and expression of two key enzymes involved in its synthesis, namely Ǆ-
butyrobetainealdehyde dehydrogenase (BADH) and butyrobetaine dioxygenase (BBDOX) 
(Lemire et al, 2011b). Along with the downregulated enzymes, the impeded TCA cycle 
blocks the steady supply of KG needed for L-carnitine synthesis. Al-toxicity is associated 
with the formation of ROS and under oxidative stress cells undergo metabolic 
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reconfigurations. As previously mentioned the TCA cycle is modulated during Al exposure 
and therefore also during oxidative stress. An important aspect of this metabolic adaptation is 
the downregulation of KG dehydrogenase (KGDH). This enzyme is particularly sensitive to 
ROS due to the reactivity of its covalently bound lipoic acid cofactor with oxidizing species. It 
has been shown that oxidation products in the lipid membranes can go on to react with 
membrane bound proteins. For example the aldehydic product of lipid peroxidation, 4-
hydroxy-2-nonenal (HNE), reacts with the lipoic acid of KGDH, leading to the disruption of 
enzyme activity. The advantage of KGDH downregulation is the accumulation of the potent 
antioxidant KG. Like other ketoacids such as pyruvate and oxaloacetate, KG reacts with and 
nullifies ROS releasing succinate (KG’s respective product) and CO2, by a process referred to 
as non-enzymatic decarboxylation. As KG is being syphoned towards ROS sequestration, L-
carnitine synthesis decreases due to a lack of this pivotal cofactor (Figure 11) (Lemire et al, 
2011b).  
 
 
 
Fig. 10. Al leads to decreased levels of NAD+ through the inhibition of the TCA cycle. Under 
Al toxicity, aerobic metabolism comes to a halt in order to prevent further ROS formation by 
endogenous sources such as the electron transport chain in the mitochondria. Al triggers the 
metabolic shift gated by NADK towards NADP+ production. This substrate is subsequently 
reduced by various enzymes to produce NADPH. This last compound is essential in 
antioxidant defense and just as importantly, for lipogenesis (Mailloux et al, 2007b).  
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Fig. 11. Al leads to the formation of ROS, which ultimately disrupts KGDH activity (through 
interactions with the lipoic acid residue in the enzyme’s active site). The resulting KG is 
accumulated in the cell and funneled towards ROS scavenging yielding an accumulation of 
succinate. Elevated levels of succinate leads to the stabilization of the transcription factor 
HIF-1ǂ leading to the promotion of anaerobic metabolism. The supply of KG is utilized for 
sequestration of ROS and L-carnitine synthesis is hindered. Hence, there is decreased 
expression of key enzymes in the synthesis pathway. This amino acid is responsible for fatty 
acid transport into the mitochondria for degradation (ǃ-oxidation) and so accumulation of 
lipids caused by Al is further enabled by a decrease in fatty acid catabolism (Lemire et al, 
2011b).  
The concomitant production of succinate during ROS scavenging by KG is a key contributor 
to the switch to anaerobic respiration. This adaptive response is initiated by the 
heterodimeric transcription factor HIF-1. HIF-1 consists of HIF-1ǂ, HIF-2ǂ and HIF-1ǃ 
subunits. HIF-1ǂ is extremely sensitive to oxygen tension and, under normoxic conditions 
(when the ETC can function properly), HIF-1ǂ is quickly degraded by prolyl hydroxylases 
(PHDs) and the ubiquitin-proteosomal degradation pathway. When the proline residues 
undergo hydroxylation (via PHD), HIF-1ǂ is targeted for degradation by the proteosome. 
Succinate is known to perturb substrate binding sites in PHD thus interfering with the 
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degradation of HIF-1ǂ. As Al and ROS lead to an accumulation of succinate due to an 
altered TCA cycle, HIF-1ǂ is stabilized and anaerobic metabolism is promoted (Mailloux et 
al, 2009; 2007a; 2006; Peyssonnaux et al, 2007). 
6. Aluminum: The missing link between obesity, chronic inflammation and 
anemia 
It is well established that Al disrupts Fe homeostasis. As exposure to this toxin leads to 
decreased absorption of Fe in the intestine, hinders its transport in the serum, and displaces 
Fe by binding to transferrin, the involvement of Al in anemia is evident. In a similar fashion 
to insulin resistance in diabetic individuals, which leads to high levels of glucose in the 
serum and low intracellular glucose concentrations, Al toxicity causes a disproportionate 
ratio of serum and cellular Fe levels. When the body experiences Al toxicity, Fe is displaced 
and released into the bloodstream. This increase in serum Fe tricks the body into thinking 
there is an excess of Fe, which would lead to limited Fe uptake and release (regulated by 
hepcidin), when in fact the Al exposed cells are in an anemic state (Del Giudice et al, 2009). 
However, the effects of Al-altered Fe metabolism extend beyond these aforementioned 
phenomena. As described in the previous section, Al displaces Fe from important 
enzymatically active proteins leading to a disruption of metabolic processes. This event 
results in a dysfunctional mitochondria geared towards lipogenesis rather than energy 
production. An excess fat accumulation and an increase in adipose tissue evoked by Al 
toxicity can lead to obesity (Mailloux et al, 2011). Obese individuals are faced with many 
obstacles including being at greater risk for cardiovascular diseases, diabetes, obstructive 
sleep apnea, certain cancers and osteoarthritis (Ausk et al, 2008). One of the hallmarks of 
obesity is chronic inflammation. Inflammation associated with obesity may be linked to Al 
exposure, a well known and readily used adjuvant. There exists a correlation between 
unhealthy eating habits and obesity and so an increased intake of processed and “fast” 
foods by an individual would suggest an increased exposure to Al. This Al could be 
responsible for the chronic inflammatory response observed in obese patients.  
Fe release from various proteins including the [Fe-S] clusters and hemes of enzymes is 
facilitated by Al. This would cause an increase in free Fe in the body, an event which is 
hazardous to an organism due to potential ROS formation and promotion of pathogen 
infection. The body’s response to increase Fe levels is the secretion of the hormonal peptide 
hepcidin. Secreted by the liver and adipose tissues, this peptide limits absorption of Fe by 
the intestine and release from stores. When gene deletions for hepcidin were performed in 
mice, unregulated hyperabsorption of Fe in the intestine and unregulated discharge of Fe 
from spleen macrophages was observed. Overexpression of the hepcidin gene in the mice 
led to Fe deficiencies and death. It is therefore obvious that this peptide is the regulator of Fe 
homeostasis.  
As an organism is exposed to Al, multiple effects can be observed. The dysfunctional 
mitochondria leads to increased intracellular lipid accumulation. Obesity sets in and chronic 
inflammation occurs. Fe homeostasis is disrupted. Together, these events may favor an 
increase in hepcidin levels in the serum which would limit further absorption of Fe, 
ultimately causing Al-induced anemia (figure 12) (Ganz, 2003). As Al is associated with ROS 
toxicity and metabolic shifts leading to the accumulation of the ketoacid antioxidants, such 
as KG and pyruvate, perhaps dietary supplementation with these potent scavengers might 
offset the effects of the metal toxin.  
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Fig. 12. A global outlook on the implications of Al toxicity leading to disruption of Fe 
homeostasis, increased lipogenesis and induction of chronic inflammation. Ultimately Al 
causes the release of Fe into the bloodstream which can signal the secretion of hepcidin by 
the liver and adipose tissue leading to the limited Fe uptake in the intestine and limited 
release from cellular stores. Al, by mimicking Fe, tricks the body into thinking it has an 
overload of the redox active metal and the body response leads to an Al induced anemic 
state.  
7. The therapeutic potential of α-ketoacids 
An important factor contributing to Al toxicity is its ability to generate an oxidative 
environment within the cell. As Al displaces Fe, this redox-active element can participate in 
ROS-generating reactions leading to the formation of toxic moieties such as hydrogen 
peroxide (H2O2), superoxide (O2·-) and the hydroxyl radical (· OH). Due to the nature of our 
oxygen-rich environment, cells are constantly challenged with the burden of oxidative 
stress. Situations such as Al toxicity worsen the oxidative load that aerobic organisms are 
exposed to. Hence, organisms possess a battery of antioxidant systems that maintain the 
redox balance of their cells. With the classical antioxidants molecules such as glutathione 
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(GSH), ascorbic acid (AA) and vitamin E being extensively studied, the importance of ǂ-
ketoacids as ROS scavengers has begun to emerge.  
ǂ-Ketoacids are organic compounds that contain a carboxylic acid group adjacent to a 
ketone group. They play an essential role in cellular metabolism as intermediates in many 
pathways including the TCA cycle and glycolysis. Examples of biologically relevant ǂ-
ketoacids include pyruvate, ǂ-ketoglutarate, oxaloacetate and glyoxylate. The antioxidant 
potential of these substrates has been demonstrated in a variety of ways. For example, in the 
soil microbe Pseudomonas fluorescens the ǂ-ketoacids KG and pyruvate are readily 
accumulated for ROS scavenging in conditions of oxidative stress induced by exogenous 
H2O2, menadione (a O2·- generator), and Al (Mailloux et al, 2008). Similarly, metabolic 
adaptations occur in cultured human hepatocytes and astrocytes leading to the 
accumulation of these ǂ-ketoacids when the cells are exposed to Al and other oxidizing 
agents (Lemire et al, 2011, Mailloux et al, 2011).  
In a clinical setting, numerous studies have shown the benefits of ǂ-ketoacid 
supplementation in an effort to prevent or rectify oxidative damage. An area of this research 
includes the prevention of cataract formation by pyruvate. Cataracts cause the clouding that 
develops in the crystalline lens of the eye, which can vary from a slight or complete degree 
of opacity and obstruction of the passage of light. Cataract formation has been linked to 
diabetes, hypertension and the over-exposure to UV-radiation. Although treatment with 
surgery and replacement with synthetic implants are options, there is a push for the 
development of pharmacological means of cataract prevention, which would reduce 
invasiveness and cause less secondary effects. The UV-radiation hypothesis of cataract 
formation states that photons penetrate through to the cornea and subsequently cause the 
generation of photochemically derived ROS in the aqueous humour and lens of the eye. 
Fittingly, cataract formation is accompanied by many signs of oxidative stress such as 
excessive protein glycation and lipid peroxidation, depletion of GSH and a decrease in 
ATP levels. In vitro incubation of mice and rat eye lens with pyruvate demonstrated the 
beneficial effect of this ǂ-ketoacid in preventing cataract formation by scavenging ROS. 
These studies demonstrate the therapeutic potential of pyruvate in offsetting the 
cataractogenesis effects of solar radiation and other factors that act via ROS toxicity 
(Hegde, 2007, Hegde, 2005).  
The use of ǂ-ketoacids in the detoxification of ROS has been shown in many other cases. In 
numerous brain pathologies such as neurodegenerative diseases or in acute injuries such as 
ischemia or trauma, H2O2 is a suspected culprit in the development of neuropathogenesis. A 
study by Desagher et al. examined the ability of pyruvate to improve the survival of 
cultured striatal neurons exposed to oxidative agents. Pyruvate protected neurons against 
both H2O2 added to the external medium and O2·- endogenously produced through the 
redox cycling agent menadione. The neuroprotective effect of pyruvate appeared to result 
from the ability of the ǂ-ketoacid to undergo non-enzymatic decarboxylation in the presence 
of ROS. In addition, several other ǂ-ketoacids including ǂ-ketobutyrate, which is not an 
energy substrate, also provided the neuroprotective effect of pyruvate. This study also 
showed that optimal neuroprotection was achieved with relatively low concentrations of 
pyruvate (>1mM) and that due to its low toxicity and its capacity to cross the blood-brain 
barrier, this ǂ-ketoacid opens a new therapeutic perspective in ROS associated-brain 
pathologies (Desagher, 1997).  
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The advantages of ǂ-ketoacid supplementation for the cardiovascular system have been 
demonstrated in numerous settings including cardiopulmonary bypass surgery, 
cardiopulmonary resuscitation, myocardial stunning, and cardiac failure. An important 
factor in these situations includes the trauma brought upon by myocardial ischemia. As the 
muscles of the heart are re-oxygenated after a prolonged anaerobic period, the tissue is faced 
with a depleted energy supply and a massive burst of ROS formation. Therapy with 
pyruvate has been shown to decrease the damage caused to the ischemic myocardium after 
reperfusion (Mallet et al., 2005).  
The clinical use of ǂ-ketoacids along with their natural occurrence as an antioxidant shows 
promise of a new line of therapeutic drugs against a wide variety of diseases and 
dysfunctions. Since Al toxicity is linked to disease states such as obesity, chronic 
inflammation and anemia, ǂ-ketoacids supplementation may perhaps offer a treatment for 
the effects of this ROS-forming metal toxin.  
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